SAFETY AND IMMUNOGENICITY OF A LIVE RECOMBINANT MEASLES VECTOR BASED CHIKUNGUNYA VACCINE IN HEALTHY ADULTS: A RANDOMIZED, PLACEBO CONTROLLED PHASE 2 STUDY

被引：0
|
作者：
Schrauf, Sabrina [1 ]
Ramsauer, Katrin [1 ]
Muellner, Matthias [1 ]
Pfeiffer, Andrea [1 ]
Kort, Alexander [1 ]
Tauber, Erich [1 ]
机构：
[1] Themis Biosci GmbH, Vienna, Austria
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 97卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
2
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [1] A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults
    Shaw, Christine A.
    August, Allison
    Bart, Stephan
    Booth, Peta-Gay Jackson
    Knightly, Conor
    Brasel, Trevor
    Weaver, Scott C.
    Zhou, HongHong
    Panther, Lori
    [J]. VACCINE, 2023, 41 (26) : 3898 - 3906
  • [2] Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
    Osorio, Jorge E.
    Velez, Ivan D.
    Thomson, Cynthia
    Lopez, Liliana
    Jimenez, Alejandra
    Haller, Aurelia A.
    Silengo, Shawn
    Scott, Jaclyn
    Boroughs, Karen L.
    Stovall, Janae L.
    Luy, Betty E.
    Arguello, John
    Beatty, Mark E.
    Santangelo, Joseph
    Gordon, Gilad S.
    Huang, Claire Y-H
    Stinchcomb, Dan T.
    [J]. LANCET INFECTIOUS DISEASES, 2014, 14 (09): : 830 - 838
  • [3] Safety and Immunogenicity of a Live Oral Recombinant Cholera Vaccine VA1.4: A Randomized, Placebo Controlled Trial in Healthy Adults in a Cholera Endemic Area in Kolkata, India
    Kanungo, Suman
    Sen, Bandana
    Ramamurthy, Thandavarayan
    Sur, Dipika
    Manna, Byomkesh
    Pazhani, Gururaja P.
    Chowdhury, Goutam
    Jhunjhunwala, Puja
    Nandy, Ranjan K.
    Koley, Hemanta
    Bhattacharya, Mihir Kumar
    Gupta, Sanjay
    Goel, Gaurav
    Dey, Bindu
    Thungapathra, M.
    Nair, G. Balakrish
    Ghosh, Amit
    Mahalanabis, Dilip
    [J]. PLOS ONE, 2014, 9 (07):
  • [4] Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
    Sirivichayakul, Chukiat
    Barranco-Santana, Elizabeth A.
    Esquilin-Rivera, Ines
    Oh, Helen M. L.
    Raanan, Marsha
    Sariol, Carlos A.
    Shek, Lynette P.
    Simasathien, Sriluck
    Smith, Mary Kathryn
    Dario Velez, Ivan
    Wallace, Derek
    Gordon, Gilad S.
    Stinchcomb, Dan T.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (10): : 1562 - 1572
  • [5] A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults
    Gunale, Bhagwat
    Farinola, Nicholas
    Yeolekar, Leena
    Shrivastava, Shubham
    Girgis, Hanna
    Poonawalla, Cyrus S.
    Dhere, Rajeev M.
    Arankalle, Vidya
    Mishra, Akhilesh Chandra
    Mehla, Rajeev
    Kulkarni, Prasad S.
    [J]. VACCINE, 2023, 41 (38) : 5614 - 5621
  • [6] A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults
    Sheldon, Eric
    Kitchin, Nicholas
    Peng, Yahong
    Eiden, Joseph
    Gruber, William
    Johnson, Erik
    Jansen, Kathrin U.
    Pride, Michael W.
    Pedneault, Louise
    [J]. VACCINE, 2016, 34 (18) : 2082 - 2091
  • [7] Safety and Immunogenicity of a Recombinant Tetanus Vaccine in Healthy Adults in China: A Randomized, Double-Blind, Dose Escalation, Placebo- and Positive-Controlled, Phase 1/2 Trial
    Xu, Xiaowei
    Yu, Rui
    Xiao, Lanlan
    Wang, Jie
    Yu, Meihong
    Xu, Junjie
    Tan, Yajun
    Ma, Xiao
    Wu, Xiaoxin
    Lian, Jiangshan
    Huang, Kaizhou
    Ouyang, Xiaoxi
    Bi, Sheng
    Wu, Shipo
    Wang, Xiaoyan
    Jin, Jiandi
    Yu, Ling
    Zhang, Huafen
    Wei, Qi
    Shi, Jinfa
    Chen, Wei
    Li, Lanjuan
    [J]. ADVANCED SCIENCE, 2021, 8 (15)
  • [8] Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial
    Salmon-Ceron, Dominique
    Durier, Christine
    Desaint, Corinne
    Cuzin, Lise
    Surenaud, Mathieu
    Ben Hamouda, Nadine
    Lelievre, Jean-Daniel
    Bonnet, Benedicte
    Pialoux, Gilles
    Poizot-Martin, Isabelle
    Aboulker, Jean-Pierre
    Levy, Yves
    Launay, Odile
    [J]. AIDS, 2010, 24 (14) : 2211 - 2223
  • [9] Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study
    Sirivichayakul, Chukiat
    Barranco-Santana, Elizabeth A.
    Rivera, Ines Esquilin
    Kilbury, Jennifer
    Raanan, Marsha
    Borkowski, Astrid
    Papadimitriou, Athanasia
    Wallace, Derek
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (09): : 1513 - 1520
  • [10] A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
    Aliprantis, Antonios O.
    Shaw, Christine A.
    Griffin, Paul
    Farinola, Nicholas
    Railkar, Radha A.
    Cao, Xin
    Liu, Wen
    Sachs, Jeffrey R.
    Swenson, Christine J.
    Lee, Heather
    Cox, Kara S.
    Spellman, Daniel S.
    Winstead, Colleen J.
    Smolenov, Igor
    Lai, Eseng
    Zaks, Tal
    Espeseth, Amy S.
    Panther, Lori
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (05) : 1248 - 1261
12345